Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
- PMID: 2359137
- DOI: 10.1093/jnci/82.13.1113
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines
Abstract
The National Cancer Institute (NCI) is implementing a large-scale in vitro drug-screening program that requires a very efficient automated assay of drug effects on tumor cell viability or growth. Many laboratories worldwide have adopted a microculture assay based on metabolic reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). However, because of certain technical advantages to use of the protein-binding dye sulforhodamine B (SRB) in a large-scale screening application, a detailed comparison of data generated by each type of assay was undertaken. The MTT and SRB assays were each used to test 197 compounds, on simultaneous days, against up to 38 human tumor cell lines representing seven major tumor categories. On subsequent days, 38 compounds were retested with the SRB assay and 25 compounds were retested with the MTT assay. For each of these three comparisons, we tabulated the differences between the two assays in the ratios of test group values to control values (T/C) for cell survival; calculated correlation coefficients for various T/C ratios; and estimated the bivariate distribution of the values for IC50 (concentration of drug resulting in T/C values of 50%, or 50% growth inhibition) for the two assays. The results indicate that under the experimental conditions used and within the limits of the data analyses, the assays perform similarly. Because the SRB assay has practical advantages for large-scale screening, however, it has been adopted for routine use in the NCI in vitro antitumor screen.
Similar articles
-
Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.Anticancer Drugs. 1996 May;7(3):331-8. Anticancer Drugs. 1996. PMID: 8792008
-
A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines.Eur J Cancer. 1993;29A(3):395-9. doi: 10.1016/0959-8049(93)90394-u. Eur J Cancer. 1993. PMID: 8398340
-
Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays.BMC Res Notes. 2015 Feb 20;8:47. doi: 10.1186/s13104-015-1000-8. BMC Res Notes. 2015. PMID: 25884200 Free PMC article.
-
Evaluation of in vitro chemosensitivity using human lung cancer cell lines.J Cell Biochem Suppl. 1996;24:160-4. doi: 10.1002/jcb.240630511. J Cell Biochem Suppl. 1996. PMID: 8806098 Review.
-
Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia.Leuk Lymphoma. 2003 Nov;44(11):1957-62. doi: 10.1080/1042819031000116607. Leuk Lymphoma. 2003. PMID: 14738150 Review.
Cited by
-
Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.Bioorg Med Chem Lett. 2015 Jul 15;25(14):2763-7. doi: 10.1016/j.bmcl.2015.05.019. Epub 2015 May 16. Bioorg Med Chem Lett. 2015. PMID: 26022840 Free PMC article.
-
Advances in antitumor research of CA-4 analogs carrying quinoline scaffold.Front Chem. 2022 Oct 28;10:1040333. doi: 10.3389/fchem.2022.1040333. eCollection 2022. Front Chem. 2022. PMID: 36385996 Free PMC article. Review.
-
Cholesterol biosynthesis inhibitor RO 48-8071 suppresses growth of hormone-dependent and castration-resistant prostate cancer cells.Onco Targets Ther. 2016 May 30;9:3223-32. doi: 10.2147/OTT.S105725. eCollection 2016. Onco Targets Ther. 2016. PMID: 27313468 Free PMC article.
-
Biosynthesis of copper nanoparticles using aqueous Tilia extract: antimicrobial and anticancer activities.Heliyon. 2018 Dec 20;4(12):e01077. doi: 10.1016/j.heliyon.2018.e01077. eCollection 2018 Dec. Heliyon. 2018. PMID: 30603710 Free PMC article.
-
Systematic analyses of the cytotoxic effects of compound 11a, a putative synthetic agonist of photoreceptor-specific nuclear receptor (PNR), in cancer cell lines.PLoS One. 2013 Sep 16;8(9):e75198. doi: 10.1371/journal.pone.0075198. eCollection 2013. PLoS One. 2013. PMID: 24066170 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources